Showing results (101-110 of 111) with videos related to
Sort By:
Pageof 12
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 2, 2025
Evaluating the necessity of two-point sampling for vancomycin area under the curve in follow-up therapeutic drug monitoringAyako Suzuki, Hisato Fujihara, Fumihiro Yamaguchi, et al.Pharmaceutical Research|October 21, 2024
Identification of Patients Who Require Two-Point Blood Sampling for the Peak and Trough Values Rather Than One-Point Blood Sampling for the Trough Value for the Evaluation of AUC of Vancomycin Using Bayesian EstimationAyako Suzuki, Masaru Samura, Tomoyuki Ishigo, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 11, 2026
Comparison of area under the concentration-time curve estimations between Practical Antimicrobial Therapeutic Drug Monitoring (PAT) versions 3 and 4 for vancomycin using two-point samplingAyako Suzuki, Hisato Fujihara, Fumihiro Yamaguchi, et al.Microbiology Spectrum|May 22, 2024
Relationship between nephrotoxicity and area under the concentration-time curve of vancomycin in critically ill patients: a multicenter retrospective studyTomoyuki Ishigo, Kazuaki Matsumoto, Hiroaki Yoshida, et al.The Journal of Pharmacy and Pharmacology|June 16, 2025
Risk stratification of AUC upward deviation in patients with low serum creatinine levels treated with vancomycin: a multicenter retrospective studyTomoyuki Ishigo, Ayako Suzuki, Yuta Ibe, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 24, 2025
Development and external validation of a population pharmacokinetic model and optimal Vancomycin dosing regimen for overweight and obese patientsToshiaki Komatsu, Atsushi Tomizawa, Masaru Samura, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|April 10, 2025
External validation of a flowchart related to achieving the target area under the concentration-time curve for vancomycin: A retrospective multicenter studyTomoyuki Ishigo, Ayako Suzuki, Yuta Ibe, et al.Journal of Pharmaceutical Health Care and Sciences|March 13, 2025
Development and validation of a population pharmacokinetic model of vancomycin for patients of advanced ageKeisuke Takada, Masaru Samura, Yuki Igarashi, et al.The Journal of Antimicrobial Chemotherapy|February 4, 2026
Development of a risk prediction model for vancomycin-associated acute kidney injury: a multicentre retrospective studyTomoyuki Ishigo, Ayako Suzuki, Yuta Ibe, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 4, 2023
Flowchart for predicting achieving the target area under the concentration-time curve of vancomycin in critically ill Japanese patients: A multicenter retrospective studyTomoyuki Ishigo, Satoshi Fujii, Yuta Ibe, et al.Pageof 12